Lupin's Joint Airways Initiative surpasses 10,000 Patients

Global pharma major Lupin Limited (Lupin) announced today that it's digital asthma educator platform, Joint Airways Initiative (JAI), has now onboarded over 10,000 patients since its launch.

JAI, a visionary initiative by Lupin, equips patients with the knowledge and skills to manage their condition effectively. By offering a comprehensive range of services, including personalized inhalation technique guidance, pulmonary physiotherapy, dietary counselling, yoga, and medication adherence, JAI is committed to enhancing treatment outcomes and overall well-being. This is India's first digital asthma educator platform.

As per the Global Asthma Report 2022, 35 million Indians suffer from asthma and COPD, with less than 30% of them being aware of their condition. 90% of those diagnosed utilize their inhalers incorrectly, adversely impacting their treatment progress and overall health. JAI has bridged this gap by providing personalized, one-on-one training sessions to over 10,000 onboarded patients from qualified asthma educators on correct inhalation techniques.

For additional information on JAI, please visit www.jairespi.com or connect via the toll-free number 1800 267 9820.

Mr. Rajeev Sibal, President - India Regions Formulations, Lupin, said, "At Lupin, we are committed to placing patients at the heart of our initiatives. Given the alarming surge in asthma and COPD cases in India, largely linked to air pollution, there was an urgent need to educate patients on correct inhalation techniques to improve treatment outcomes. As leaders of respiratory therapy in India, JAI represents our endeavour to raise patient awareness and empower them to breathe better. We are delighted to have onboarded over 10,000 patients and supported them on their journey to better lung health."

"In the post-COVID era, patients are increasingly turning to digital interventions for their healthcare needs," said Mr. Hirak Bose, Vertical Head Sales & Marketing - Respiratory, Lupin. "With JAI, we have successfully reached out to patients, emphasizing the importance of correct inhalation techniques and lifestyle management for asthma and COPD. This milestone is a testament to our commitment to enhancing patient experiences, positively impacting their lung health journey, and providing better quality of life."

Shares of Lupin Limited was last trading in BSE at Rs. 1132.30 as compared to the previous close of Rs. 1109.45. The total number of shares traded during the day was 17490 in over 1487 trades.

The stock hit an intraday high of Rs. 1134.45 and intraday low of 1106.25. The net turnover during the day was Rs. 19708694.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 DigitalAsthmaEducatorPlatform JointAirwaysInitiative